| RS2517440116 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517440229 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517440416 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Acute myeloid leukemia |
| RS2517441155 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517442155 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517442308 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2517442346 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517442518 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS2517442774 |
MCM3AP
|
Health Risk |
Likely pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS2517443210 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517445086 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517445160 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS2517445243 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517447078 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517447331 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517447876 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517448132 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517450962 |
SEC23B
|
Health Risk |
Likely pathogenic |
— |
| RS2517451331 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517452643 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517452797 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517453201 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517453236 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS2517453736 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517454033 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517454427 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517455884 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS2517457737 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517457847 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517460527 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS2517463579 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS2517469276 |
SYCP2
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2517469335 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517469721 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517469815 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517470142 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517470416 |
DONSON
|
Health Risk |
Likely pathogenic |
Microcephaly, short stature |
| RS2517470463 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517470846 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517471083 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517473808 |
SEC23B
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517473941 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2517474861 |
DONSON
|
Health Risk |
Likely pathogenic |
Microcephaly, short stature |
| RS2517474921 |
DONSON
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517475167 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517475620 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517476743 |
COMT
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2517481120 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517481800 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517481810 |
SYCP2
|
Health Risk |
Likely pathogenic |
Oligosynaptic infertility, Oligosynaptic infertility |
| RS2517482273 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517482439 |
SEC23B
|
Health Risk |
Likely pathogenic |
— |
| RS2517482498 |
RUNX1
|
Health Risk |
Pathogenic |
RUNX1-related disorder, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517482635 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517483215 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517483238 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517483376 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517483521 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517483668 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517484633 |
TRAPPC10
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, short stature |
| RS2517484685 |
DONSON
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS2517484911 |
DONSON
|
Health Risk |
Likely pathogenic |
— |
| RS2517485238 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517485589 |
SEC23B
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517485865 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517485892 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517486812 |
RUNX1
|
Health Risk |
Pathogenic |
RUNX1-related disorder, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517487922 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517488147 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517488790 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517489991 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517501162 |
MYO18B
|
Health Risk |
Pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS2517508341 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517512756 |
SEC23B
|
Health Risk |
Pathogenic |
— |
| RS2517513022 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517523586 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517523659 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517525537 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2517529277 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517530686 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2517531900 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS2517532919 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517541465 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2517546260 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517546301 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517546930 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547106 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547488 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547588 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547806 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547824 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517547973 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517548062 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517548621 |
DRG1
|
Health Risk |
Likely pathogenic |
Tan-Almurshedi syndrome, Tan-Almurshedi syndrome |
| RS2517548883 |
CDC45
|
Health Risk |
Likely pathogenic |
— |
| RS2517553761 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2517554170 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2517554532 |
CDC45
|
Health Risk |
Likely pathogenic |
Meier-Gorlin syndrome 7, Meier-Gorlin syndrome 7 |
| RS2517557197 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2517574437 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |